Login / Signup

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.

Jolynne MokayaEdward A O BurnCynthia Raissa TamandjouDominique GoedhalsEleanor J BarnesMonique AnderssonRafael Pinedo-VillanuevaPhilippa Clare Matthews
Published in: BMC public health (2019)
Given the long-term health burden for individuals and economic burden for society associated with chronic HBV infection, screening pregnant women and providing tenofovir for all who test HBsAg+ may be a cost-effective strategy for South Africa and other low/middle income settings.
Keyphrases
  • hepatitis b virus
  • south africa
  • pregnant women
  • mental health
  • hiv positive
  • liver failure
  • antiretroviral therapy
  • healthcare
  • public health
  • physical activity
  • risk factors
  • hepatitis c virus
  • risk assessment
  • hiv infected